EUTM file information

018406998

SIENNA

February 22, 2021

Trademark Summary

The trademark application SIENNA was filed by T & D DIAGNOSTICS CANADA PVT. LTD., a corporation established under the laws of Canada (the "Applicant"). The application was published for oppositions on June 29, 2021, and it was registered by office on October 6, 2021 without any oppositions.

The application was filed in English (Spanish was selected as the second language).

Change of name and address of the trademark registration was recorded on May 3, 2022.

Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, respiratory tract infections including COVID-19, Influenza A, Influenza A plus B, Strep A, Respiratory Syncytial Virus Antigen (RSV), Adenovirus pneumonia Antigen, Legionella pneumophilia, Streptococcus pneumoniae, Mycoplasma pneumonia Antigen and Antibody, Mononucleosis (MONO) and EBV VCA IgB and EBNA IgG
    2. Diagnostic kits comprised of medical diagnostic assays for use in disease detection, screening, treating and monitoring, namely, monitoring COVID-19
    3. Respiratory rapid tests, namely, assays for use in performing respiratory rapid tests related to COVID-19
    4. Screening tests and devices to detect COVID-19 in a patient.
  • The mark was filed in class 9 with following description of goods:
    1. Scientific apparatus and instruments, namely, COVID-19 rapid tests for withdrawing and testing respiratory droplets for research, and scientific purposes and parts and fittings thereof
    2. Scientific research and laboratory apparatus and instruments, namely, apparatus and instruments for use in connection with assays
    3. Material testing apparatus and instruments, for identifying and testing pathogens and biomarkers in respiratory droplets for research, and scientific purposes related to COVID-19
    4. Apparatus for transmission of communication
    5. Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for research, and scientific purposes, namely, for COVID-19.
  • The mark was filed in class 10 with following description of goods:
    1. COVID-19 rapid tests for withdrawing and testing respiratory droplets for clinical and medical purposes and parts and fittings thereof
    2. Material testing apparatus and instruments, for identifying and testing pathogens and biomarkers in respiratory droplets for clinical and medical purposes related to COVID-19
    3. Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for clinical and medical purposes, namely, for COVID-19.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific research in the field of virology and infectious diseases
    2. Scientific study and research in the fields of respiratory tract infection detection
    3. Research and development of rapid respiratory assay tests, namely, for COVID-19, for others in the medical field.
Trademarkers